MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-16881

  1. 16,651 Posts.
    lightbulb Created with Sketch. 2375
    The Annual Financial report suggested that the meetings for "Chronic Heart Failure" and "Disgogenic Back Pain" with the FDA had already taken place and had been "productive", although no announcement was made at the time.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.